T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients
Seminars in Arthritis and Rheumatism Jun 26, 2019
Poindron V, et al. - Via a study on 72 patients fulfilling the ACR/EULAR classification criteria for systemic sclerosis (SSc, an immune-mediated systemic rheumatic disease), the researchers ascertained the prevalence of cardiac involvement by cardiac magnetic resonance imaging (CMR) native T1 mapping and its correlation with echocardiography data and non-cardiac signs. No cardiac symptoms, normal echocardiography, and CMR left ventricular ejection fraction, and no Late Gadolinium Enhancement was observed in 36% of patients with elevated T1 (ET1). In 50% of patients with SSc, native T1 mapping identified left ventricular ET1 (potential diffuse myocardial fibrosis) and a normal conventional screening including standard CMR of a third of them was observed. Hence, further studies to strengthen the benefit of use of native T1 mapping as a part of routine follow up to detect earlier pejorative cardiac involvement in SSc patients is suggestive.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries